Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter to Lohxa LLC, issued September 10, 2019, addresses compliance concerns with drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The FDA's drug regulatory authority was engaged in this enforcement action, though the specific issuing office is not identified in the metadata provided.